Prioritizing the safety and capacity of reconstruction workers can speed up the disaster recovery process and make communities more resilient to future hazards, write Drs. William Brett Perkison and Bill Christian, researchers at UTHealth Houston.
William Brett Perkison, Bill ChristianOctober 23, 2023
By Michael W. Deem, Melia E. Bonomo and Kirstin R.W. Matthews
Due to the rapidly mutating influenza virus, a new vaccine is usually developed for each flu season. In this policy brief, the authors discuss the current method used by the Centers for Disease Control and Prevention to develop the flu vaccine and propose the use of mathematical modeling to improve the vaccine's effectiveness.
Michael W. Deem, Melia E. Bonomo, Kirstin R.W. MatthewsOctober 29, 2018
Ambassador Edward P. Djerejian, director of the Baker Institute, makes the case for a comprehensive North American strategy in which the U.S., Mexico and Canada act in concert to become the global superpower of the 21st century.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.
Ambassador Edward P. Djerejian, director of the Baker Institute, describes the key elements of a coherent strategy for defeating ISIS, incorporating both nearer-term strategies and long-term approaches.
The Nov. 13 terrorist attacks in Paris demonstrated a change in strategy by the Islamic State — a willingness to strike outside of the Middle East. But this also yields an opportunity for a U.S.-led coalition to come together to defeat a common enemy, writes Baker Institute director Ambassador Edward P. Djerejian.